Trials / Completed
CompletedNCT00125684
Bioavailability and Effectiveness of Transdermally Administered Morphine
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Alberta Health services · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Patients will participate in two arms of the trial, one in which morphine will be administered transdermally, and, after a 3 day wash out period, one in which morphine will be administered subcutaneously.
Detailed description
Patients will participate in two arms of the trial, one in which morphine will be administered transdermally, and, after a 3 day wash out period, one in which morphine will be administered subcutaneously. Blood draws will be done after both dosing methods in order to compare blood levels of morphine by the different routes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | morphine |
Timeline
- Start date
- 2003-07-01
- Primary completion
- 2007-07-01
- Completion
- 2008-07-01
- First posted
- 2005-08-02
- Last updated
- 2012-01-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00125684. Inclusion in this directory is not an endorsement.